Algert Global’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-83,847
Closed -$832K 1179
2025
Q2
$832K Buy
+83,847
New +$884K 0.02% 844
2024
Q3
Sell
-12,496
Closed -$140K 1285
2024
Q2
$140K Buy
+12,496
New +$145K ﹤0.01% 1338
2022
Q3
Sell
-10,167
Closed -$128K 1209
2022
Q2
$128K Sell
10,167
-56,520
-85% -$600K 0.01% 1082
2022
Q1
$723K Buy
66,687
+42,602
+177% +$517K 0.05% 663
2021
Q4
$339K Sell
24,085
-17,718
-42% -$292K 0.04% 688
2021
Q3
$803K Buy
+41,803
New +$555K 0.11% 337

Other funds holding DVAX

Algert Global's DVAX Position: Q3 2025 in Review

Algert Global sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 83,847 shares — an estimated $832K sold.

Algert Global first reported a position in DVAX in Q3 2021 and held it in 6 quarters. The position peaked at $832K in Q2 2025. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • Algert Global reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • Algert Global sold 83,847 Dynavax Technologies shares in Q3 2025, an estimated $832K.
  • Algert Global first reported a position in Dynavax Technologies in Q3 2021 and held it in 6 quarters.
  • Algert Global's Dynavax Technologies position peaked at $832K in Q2 2025.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on Algert Global's 13F filing for Q3 2025, filed 14 Nov 2025.